Attached files
| file | filename |
|---|---|
| 10-K/A - SPRING PHARMACEUTICAL GROUP, INC. | cyig10ka03092011.htm |
| EX-31.1 - SPRING PHARMACEUTICAL GROUP, INC. | exhibit311.htm |
| EX-31.2 - SPRING PHARMACEUTICAL GROUP, INC. | exhibit312.htm |
* * * * *
EXHIBIT 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED PURSUANT TO SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned officers each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of China YCT International Group, Ltd. on Form 10-K/A for the fiscal year ended March 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Annual Report on Form 10-K/A fairly presents in all material respects the financial condition and results of operations of the Company.
|
Date: March 9, 2011
|
/s/ Yan Tinghe
|
Yan Tinghe, Chief Executive Officer
|
Date: March 9, 2011
|
/s/ Li Chuanmin
|
Li Chuanmin, Chief Financial Officer
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.